Type of MS: RRMS|SPMS
Treatment mode of action: To affect immune function
Number of Subjects: 734
Medication: Fenebrutinib, a highly selective, orally administered inhibitor of BTK
Location: Colorado
Institutions: Advanced Neurology of CO/Advanced Neurosciences Research
2121 East Harmony Road Suite 180 Fort Collins CO 80528
Contact Information
Jennifer Gentilcore
970-237-2979
advneurosciences@gmail.com